Remote Patient Monitoring, Explained: The 2026 Field Guide
What remote patient monitoring covers, why it matters in 2026, and the numbers decision-makers should know.
Budget season has a way of clarifying priorities, and this year the spotlight is on remote patient monitoring. RPM programs, devices, and the reimbursement rules that govern them. This explainer sets out what the category actually covers, why it has moved to the center of wearables & rpm strategy, and the numbers every decision-maker should have at hand.
What it covers
RPM programs, devices, and the reimbursement rules that govern them. In practice, that spans the vendors building the technology, the health systems and payers deploying it, and the regulators writing the rules around it. The category sits inside our broader Wearables & RPM coverage, and its daily developments stream into the live Remote Patient Monitoring feed.
Why it matters in 2026
Consider the current numbers: medicare remote patient monitoring spending has passed $500 million a year, and CMS has proposed consolidating seventeen RPM codes into four by 2027 (our coverage).
Meanwhile, dexcom won authorization for a 15.5-day CGM sensor with 8.0% MARD accuracy (our coverage).
Meanwhile, global wearable shipments now exceed 136.5 million units per quarter.
What to watch next
Three signals will tell you where remote patient monitoring goes from here: the reimbursement decisions now moving through CMS and commercial payers, the consolidation pattern as larger platforms absorb point solutions, and the evidence base - peer-reviewed results increasingly separate durable categories from demo-ware.
The bottom line
For leaders building 2027 plans, this belongs on the shortlist of capabilities to own rather than outsource. For the latest developments, follow our continuously updated Remote Patient Monitoring topic page.